EV/EBITDA
-1.00
+0.10+9.09%
34 min ago
Summary
- As of February 24, 2025, RNAC EV/EBITDA is -1.00, with a rise of +0.10 (+9.09%) during the most recent trading day.
- Over the past year, RNAC EV/EBITDA has dropped by -0.78 (-354.55%).
- RNAC EV/EBITDA is now -117.67% below its all-time high of 5.66.
Performance
RNAC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RNAC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +9.1% | -9.1% | -5.3% |
| 1 m1 month | +9.1% | -8.8% | -5.2% |
| 3 m3 months | 0.0% | -0.1% | -0.1% |
| 6 m6 months | -11.1% | +19.1% | +32.4% |
| ytdytd | -3.1% | +3.0% | +1.7% |
| 1 y1 year | -354.6% | +405.1% | -16.9% |
| 5 y5 years | +81.9% | -10.2% | -85.6% |
RNAC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.0% | -1.21 | +17.4% | |
| 3 m | 3-month | -0.84 | -19.1% | -1.61 | +37.9% |
| 6 m | 6-month | -0.29 | -244.8% | -1.61 | +37.9% |
| 1 y | 1-year | 0.07 | -1528.6% | -2.12 | +52.8% |
| 3 y | 3-year | 5.66 | -117.7% | -27.97 | +96.4% |
| 5 y | 5-year | 5.66 | -117.7% | -60.03 | +98.3% |
| alltime | all time | 5.66 | -117.7% | -60.03 | +98.3% |
Cartesian Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.00(+3.1%) |
| 2024 | -0.97(+410.5%) |
| 2023 | -0.19(-107.1%) |
| 2022 | 2.67(-104.6%) |
| 2021 | -57.64(+1610.4%) |
| Date | Value |
|---|---|
| 2020 | -3.37(+32.7%) |
| 2019 | -2.54(+262.9%) |
| 2018 | -0.70(-73.9%) |
| 2017 | -2.68(-66.0%) |
| 2016 | -7.89 |
FAQ
- What is Cartesian Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cartesian Therapeutics?
- What is RNAC EV/EBITDA year-to-date change?
- What is Cartesian Therapeutics EV/EBITDA year-on-year change?
What is Cartesian Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAC is -1.00
What is the all time high EV/EBITDA for Cartesian Therapeutics?
Cartesian Therapeutics all-time high EV/EBITDA is 5.66
What is RNAC EV/EBITDA year-to-date change?
Cartesian Therapeutics EV/EBITDA has changed by -0.03 (-3.09%) since the beginning of the year
What is Cartesian Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAC EV/EBITDA has changed by -0.78 (-354.55%)